This photo taken on Dec 22, 2020 shows the production line of the Russian "Sputnik V" COVID-19 vaccine at a pharmaceutical plant in the Karaganda Region of Kazakhstan. (KALIZHAN OSPANOV / XINHUA)

Russia’s RDIF sovereign wealth fund said on Monday it had agreed with Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V vaccine against COVID-19 in China.

RDIF said the two sides were committed to a long-term partnership in vaccine production.